This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Alun Garner
Business Development Manager, Nucleic Acid Solutions Division at Agilent Technologies
Speaker

Profile

Alun Garner, Business Development Manager at Agilent Technologies, has over 30 years of experience in life sciences and biotechnology, spanning oligo manufacturing, commercial operations, process development and tech transfer. He has been with Agilent for more than 16 years, supporting the growth of oligonucleotide therapeutic services through strategic partnerships and customer-focused solutions. Prior to joining Agilent, he worked at GE Healthcare, Amersham Biosciences, Avecia and Zeneca.

Agenda Sessions

  • Achieving Quality and Regulatory Confidence in Oligo Therapeutics with Advanced Purification

    12:00pm